Cargando…

Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice

BACKGROUND: A robust evidence base is required to assist healthcare commissioners and providers in selecting effective and sustainable approaches to improve cancer diagnosis and treatment. Such evidence can be difficult to build, given the fast-paced and highly pressured nature of healthcare deliver...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadsby, Erica Wirrmann, Brown, Carson, Crawford, Claire, Dale, Glen, Duncan, Edward, Galbraith, Linda, Gold, Karen, Hibberd, Carina, McFarland, Agi, McGlashan, Jennifer, McInnes, Melanie, McNaughton, Joanne, Murray, Juliette, Radin, Esme, Teodorowski, Piotr, Thomson, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619322/
https://www.ncbi.nlm.nih.gov/pubmed/37915009
http://dx.doi.org/10.1186/s12885-023-11592-w
_version_ 1785129963729453056
author Gadsby, Erica Wirrmann
Brown, Carson
Crawford, Claire
Dale, Glen
Duncan, Edward
Galbraith, Linda
Gold, Karen
Hibberd, Carina
McFarland, Agi
McGlashan, Jennifer
McInnes, Melanie
McNaughton, Joanne
Murray, Juliette
Radin, Esme
Teodorowski, Piotr
Thomson, Jane
author_facet Gadsby, Erica Wirrmann
Brown, Carson
Crawford, Claire
Dale, Glen
Duncan, Edward
Galbraith, Linda
Gold, Karen
Hibberd, Carina
McFarland, Agi
McGlashan, Jennifer
McInnes, Melanie
McNaughton, Joanne
Murray, Juliette
Radin, Esme
Teodorowski, Piotr
Thomson, Jane
author_sort Gadsby, Erica Wirrmann
collection PubMed
description BACKGROUND: A robust evidence base is required to assist healthcare commissioners and providers in selecting effective and sustainable approaches to improve cancer diagnosis and treatment. Such evidence can be difficult to build, given the fast-paced and highly pressured nature of healthcare delivery, the absence of incentives, and the presence of barriers in conducting pragmatic yet robust research evaluations. Cancer Research UK (CRUK) has played an active part in building the evidence base through its funding of programmes to identify, evaluate and scale-up innovative approaches across the UK. The aim of this paper is to describe and explain the research design and intended approach and activities for two cancer services improvement projects in Scotland funded by CRUK. METHODS: A hybrid effectiveness-implementation study design will assess both the efficiency of the new pathways and their implementation strategies, with the aim of generating knowledge for scale-up. A range of implementation, service and clinical outcomes will be assessed as determined by the projects’ Theories of Change (ToCs). A naturalistic case study approach will enable in-depth exploration of context and process, and the collection and synthesis of data from multiple sources including routine datasets, patient and staff surveys, in-depth interviews and observational and other data. The evaluations are informed throughout by a patient/public representatives’ group, and by small group discussions with volunteer cancer patients. DISCUSSION: Our approach has been designed to provide a holistic understanding of how (well) the improvement projects work (in relation to their anticipated outcomes), and how they interact with their wider contexts. The evaluations will help identify barriers, facilitators, and unanticipated consequences that can impact scalability, sustainability and spread. By opting for a pragmatic, participatory evaluation research design, we hope to inform strategies for scaling up successful innovations while addressing challenges in a targeted manner.
format Online
Article
Text
id pubmed-10619322
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106193222023-11-02 Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice Gadsby, Erica Wirrmann Brown, Carson Crawford, Claire Dale, Glen Duncan, Edward Galbraith, Linda Gold, Karen Hibberd, Carina McFarland, Agi McGlashan, Jennifer McInnes, Melanie McNaughton, Joanne Murray, Juliette Radin, Esme Teodorowski, Piotr Thomson, Jane BMC Cancer Study Protocol BACKGROUND: A robust evidence base is required to assist healthcare commissioners and providers in selecting effective and sustainable approaches to improve cancer diagnosis and treatment. Such evidence can be difficult to build, given the fast-paced and highly pressured nature of healthcare delivery, the absence of incentives, and the presence of barriers in conducting pragmatic yet robust research evaluations. Cancer Research UK (CRUK) has played an active part in building the evidence base through its funding of programmes to identify, evaluate and scale-up innovative approaches across the UK. The aim of this paper is to describe and explain the research design and intended approach and activities for two cancer services improvement projects in Scotland funded by CRUK. METHODS: A hybrid effectiveness-implementation study design will assess both the efficiency of the new pathways and their implementation strategies, with the aim of generating knowledge for scale-up. A range of implementation, service and clinical outcomes will be assessed as determined by the projects’ Theories of Change (ToCs). A naturalistic case study approach will enable in-depth exploration of context and process, and the collection and synthesis of data from multiple sources including routine datasets, patient and staff surveys, in-depth interviews and observational and other data. The evaluations are informed throughout by a patient/public representatives’ group, and by small group discussions with volunteer cancer patients. DISCUSSION: Our approach has been designed to provide a holistic understanding of how (well) the improvement projects work (in relation to their anticipated outcomes), and how they interact with their wider contexts. The evaluations will help identify barriers, facilitators, and unanticipated consequences that can impact scalability, sustainability and spread. By opting for a pragmatic, participatory evaluation research design, we hope to inform strategies for scaling up successful innovations while addressing challenges in a targeted manner. BioMed Central 2023-11-01 /pmc/articles/PMC10619322/ /pubmed/37915009 http://dx.doi.org/10.1186/s12885-023-11592-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Gadsby, Erica Wirrmann
Brown, Carson
Crawford, Claire
Dale, Glen
Duncan, Edward
Galbraith, Linda
Gold, Karen
Hibberd, Carina
McFarland, Agi
McGlashan, Jennifer
McInnes, Melanie
McNaughton, Joanne
Murray, Juliette
Radin, Esme
Teodorowski, Piotr
Thomson, Jane
Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
title Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
title_full Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
title_fullStr Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
title_full_unstemmed Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
title_short Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
title_sort test, evidence, transition projects in scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619322/
https://www.ncbi.nlm.nih.gov/pubmed/37915009
http://dx.doi.org/10.1186/s12885-023-11592-w
work_keys_str_mv AT gadsbyericawirrmann testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT browncarson testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT crawfordclaire testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT daleglen testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT duncanedward testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT galbraithlinda testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT goldkaren testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT hibberdcarina testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT mcfarlandagi testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT mcglashanjennifer testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT mcinnesmelanie testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT mcnaughtonjoanne testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT murrayjuliette testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT radinesme testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT teodorowskipiotr testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice
AT thomsonjane testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice